A mother of two has become the first adult in the UK to try a “groundbreaking” drug which can delay the need for insulin in diabetes patients.
Hannah Robinson, a 36-year-old dentist, is being treated with teplizumab at Royal Devon University Healthcare NHS Foundation Trust after discovering during pregnancy she was in the early stages of developing type 1 diabetes.